Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's letter to the editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results. Eur Urol 2018;73:62–8 Journal Article

  

Authors:	Motzer, R. J.; Escudier, B.; Ravaud, A.
Article Title:	Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's letter to the editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results. Eur Urol 2018;73:62–8
Journal Title:	European Urology
Volume:	73
Issue:	3
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2018-03-01
Start Page:	e73
Language:	English
DOI:	10.1016/j.eururo.2017.10.022
PROVIDER:	scopus
PUBMED:	29126652
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034612427&doi=10.1016%2fj.eururo.2017.10.022&partnerID=40&md5=be285768d387b4174abee82844750d72
Notes:	Letter -- Export Date: 1 March 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/121471